Global partners join the call to end measles and rubella

Last week, the Measles & Rubella Initiative was joined by an array of partners in Geneva, for an advocacy event on October 21st, co-hosted by the International Federation of Red Cross Red Crescent Societies (IFRC), Gavi, the Vaccine Alliance and the Sabin Vaccine Institute.

The event highlighted global progress in preventing measles and rubella, the recommendations of the Midterm Review report of the Global Measles and Rubella Strategic Plan 2012-2020, just recently endorsed by SAGE, and Gavi’s new Measles and Rubella strategy.

Speakers included Dr. Margaret Chan, WHO Director-General, Mr. Elhadj As Sy, Secretary General, IFRC and Ms. Anuradha Gupta, Deputy Chief Executive Officer, Gavi, the Vaccine Alliance.  Dr. Jin Tongling, Deputy Director of EPI, People’s Republic of China was a special guest, presenting China’s experience in using measles vaccination to strengthen its routine systems.

Recent developments in global efforts to protect children against measles and rubella were also presented, culminating in a robust discussion on the steps needed to further progress towards elimination. The discussion also raised awareness within the global community of the burden of measles and rubella, that measles is a key indicator of a country’s routine immunization strength; and a key issue in complex setting and emergencies.

Our partners joined in the collective plea for stronger commitment for political support and swift action from countries and agencies to end the high toll of measles and rubella worldwide.

Measles & rubella in Europe: LSHTM and WHO EURO event: Sept 20

Measles and rubella in Europe: A process of elimination

Member States of the WHO European Region have a long-standing commitment to eliminate measles and rubella from this Region. Progress is clear, with 34 of 53 countries having interrupted transmission of either or both diseases by 2014. However, immunization coverage has stagnated, or even declined in some areas, and outbreaks continue to occur. The Region is at a critical junction: while working hard to maintain this status where it has been achieved, more must be done to identify and remove barriers to full vaccination coverage in areas and communities still threatened by these diseases. What are the next steps in the fight against measles and rubella in Europe?

The London School of Hygiene and Tropical Medicine (LSHTM) in collaboration with the WHO Regional Office for Europe will host a 1-day public event to:

  • make key audiences aware of how far we have come and what remains to be done
  • examine how some countries have overcome barriers to elimination so that others may learn from these strategies
  • review recent advances in our understanding of measles elimination, attitudes towards vaccination and accurate measurement of vaccine safety.

WHEN: Tuesday, September 20 at 10:45–18.30 Free admission – online registration required: https://www.eventbrite.co.uk/e/measles-and-rubella-in-europe-a-process-of-eliminationregistration-26897778981

WHERE: John Snow Lecture Theatre London School of Hygiene and Tropical Medicine Keppel Street London, United Kingdom

Live streaming:

  • 13:30-15:00 Recent Advances in Controlling Measles and Rubella

https://panopto.lshtm.ac.uk/Panopto/Pages/Viewer.aspx?id=2f02943b-3957-444a-be6d-307ac293d5b2

  • 15:30-17:00 Panel discussion: Challenges with Elimination and How They Can Be Overcome

https://panopto.lshtm.ac.uk/Panopto/Pages/Viewer.aspx?id=26a8f8d3-c174-4b73-9050-%20d791caeb2637

For more information: http://bit.ly/2curVbA

POTUS petition to increase funding to fight measles and rubella

Join us to support greater investment in measles and rubella mortality reduction activities. Let’s reach every child!

The Measles & Rubella Initiative faces a serious funding shortfall this year. Lack of funding has left millions of children not being vaccinated and delayed response efforts during large outbreaks in Ethiopia, South Sudan, and the Democratic Republic of Congo. Thousands of children’s lives hang in the balance, threatening to turn back the progress we have made over the past 15 years that has reduced measles mortality by 79% and saved 17.1 million lives.

Despite the availability of a safe, effective, and affordable vaccine, each day measles still kills about 315 children. M&RI has helped prevent millions of deaths through immunization, but a core contributor to the partnership – the U.S. Centers for Disease Control and Prevention – has not received a significant increase in funding for measles prevention activities since 2010.

The United Nations Foundation Shot@Life campaign is a grassroots advocacy organization that supports the UN and vaccine partners around the globe to stop deadly and disabling vaccine-preventable diseases. Right now the campaign is promoting a petition and Call to Action in support of greater U.S. government investment in measles mortality reduction activities that will save children’s lives. Please join your voice together with Shot@Life Champions and sign this petition.

Measles moves fast, but together we can move faster.